# name
Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature

# metadata.dc.description.abstract[].value
Pharmaceutical companies are reluctant to invest in research and                development (R&D) of products for neglected tropical diseases (NTDs) mainly due to the low ability-to-pay of health insurance systems and of potential consumers. The available
                preventive and curative interventions for NTDs mostly rely on
                old technologies and products that are often not adequate.
                Moreover, NTDs mostly affect populations living in remote rural
                areas and conflict zones, thereby hampering access to
                healthcare. The challenges posed by NTDs have led to the
                proliferation of a variety of public-private partnerships (PPPs)
                in the last decades. We conducted a systematic review to assess
                the functioning and impact of these partnerships on the
                development of and access to better technologies for NTDs. Our
                systematic review revealed a clear lack of empirical assessment
                of PPPs: we could not find any impact evaluation analyses, while
                these are crucial to realize the full potential of PPPs and to
                progress further towards NTDs elimination.

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature